Trials / Sponsors / Jiangsu Rec-Biotechnology Co., Ltd.
Jiangsu Rec-Biotechnology Co., Ltd.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell) Herpes Zoster | Phase 1 | 2023-02-09 |
| Completed | Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov) COVID-19 | Phase 3 | 2022-10-31 |
| Completed | Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV) COVID-19 | Phase 2 | 2022-05-30 |
| Completed | Safety, and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) COVID-19 | Phase 2 | 2022-01-31 |
| Completed | Safety, Reactogenicity and Immunogenicity Study of ReCOV Covid19 | EARLY_Phase 1 | 2021-06-18 |